folder

Do CARs need a driver's license? Adoptive cell therapy with chimeric antigen receptor-redirected T cells caused serious adverse events

Authors

  • H. Buening
  • W. Uckert
  • K. Cichutek
  • R.E. Hawkins
  • H. Abken

Journal

  • Human Gene Therapy

Citation

  • Hum Gene Ther 21 (9): 1039-1042

Abstract

  • Adoptive transfer of genetically retargeted T cells provides promise in the therapy of malignant diseases; two severe adverse events, however, due to "on-targeted" activation of modified T cells occurred in recent trials. We here discuss the challenge to balance targeted anti-tumor responses whilst avoiding destruction of healthy tissues and the need of continued and carefully designed pre-clinical and clinical evaluations.


DOI

doi:10.1089/hum.2010.131